Latest Tuberculosis treatment Stories
British medical scientists say the discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria might lead to new anti-TB drugs. Until now it was thought that M. tuberculosis bacteria in the lungs of TB patients were rapidly multiplying.
The World Health Organization announced Monday in China, more money and better science are urgently needed to rein in new strains of tuberculosis that are tough or nearly impossible to treat.
Danya Presents Findings of Pilot Study at East African Health Conference in Kenya SILVER SPRING, Md., March 23 /PRNewswire/ -- Danya International, Inc.
The U.S. tuberculosis rate fell to an all-time low of 4.2 cases per 100,000 people, or 12,898 new cases, in 2008, federal health officials said.
U.S. researchers said on Thursday that two existing drugs used in combination appear to offer great promise against the most dangerous form of tuberculosis.
A four-month treatment with the drug rifampin is better tolerated for tuberculosis than the nine-month treatment of isoniazid, Canadian researchers said. Dr.
MUHC researchers are studying a shorter treatment with fewer side effects.
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child HIV transmission in breast-fed infants.In a study led by researchers at Johns Hopkins Children's Center, risks of drug...
New research on drug-resistant tuberculosis found that the hard-to-treat disease results in death for half of patients who get it.
Concert Pharmaceuticals, a biotechnology company, has announced encouraging findings from a preclinical study suggesting that C-20081, a novel, deuterium-containing oxazolidinone antibiotic, may be suitable for once-daily oral and intravenous dosing.